This review highlights the multifactorial pathophysiological mechanisms contributing to the increased risk of venous thromboembolism as a paraneoplastic syndrome in cancer patients.
Warrants heightened VTE vigilance in cancer care; leaves open dominant pathway identification for targeted trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
H. U. Sons (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: